![](/img/cover-not-exists.png)
Early landmark analysis of imatinib treatment in CML chronic phase: Less than 10% BCR-ABL by FISH at 3 months associated with improved long-term clinical outcome
Lotta Ohm, Ingrid Arvidsson, Gisela Barbany, Robert Hast, Leif StenkeVolume:
87
Year:
2012
Language:
english
Pages:
1
DOI:
10.1002/ajh.23238
File:
PDF, 914 KB
english, 2012